* SKULD-TECH *
1999 - Méditerranée
Montpellier
www.skuldtech.com Design, Diagnostics
(also, contract, research)
Key words: Biomarkers, Genomics, Pharmaco-genomics, Bio-informatics, Biosensors, SAGE
Mission: to select and validate biomarkers, bioinformatics, biosensors, leading to design new diagnosis, identify new targets, and generate new leads for biopharmaceutical companies and personalized medicine
Clients: Research labs
info@skuldtech.com
Age: 12 year(s)
Identity| TYPE/MANAGEMENT/INVESTORS | FINANCES/STATUS |
|---|
| Spin-off |
Managing Dir.-CEO: Ritter (Didier) [co-founder, born 1969, Ms. molecular biology, MBA, ex-Bio2R (founder)]
Sc.Dir.-CSO: Piquemal (David) [co-founder, Ph.D., Prof. genomics]
Fin.Dir.-CFO: Outrebon (Philippe) [co-founder, Ms. sciences, ex-Ernst & Young]
BusDev: Outrebon (Philippe)
Financers (Hist.): Oseo, Regional Territory Body, Private Investors | Turnover (M€) : 0.23 (2009), 0.21 (2008), 0.1 (2006)
Total funding (M€) : n.a.
Last funding (M€) : n.a.
Focus : Multiple
Position : Preclin
Company confirm : neutral |
History | DATE | MILESTONE | TYPE | TIME |
|---|
| 2007 .02 | Partnering research agreement with Roche Diagnostics on rapid and accurate SAGE gene profiles | R&D | [7 years] |
| 2006 .03 | Partnering research agreement with Genepep | R&D | [6 years] |
| 1999 .06 | Company founded by Didier Ritter, Dr Philippe Piquemal, Philippe Outrebon, as a spin-off from Institut de Génétique Humaine (Montpellier) | ORGF | [0 year] | Actualisation / Updating: 28-Sep-2011 |
|
